Updated: Oct 3
Check out Higher Learning LV's new Cannabis for Cancer Hub, which offers convenient access to our entire collection of no-cost Study Summaries and Deep Dives about how cannabis/hemp/marijuana may help some cancer patients.
An August 2022 study entitled "Association Between Cannabis Use with Urological Cancers: A Population-based Cohort Study in the UK Biobank" that was published in the journal Cancer Medicine investigated the potential results of using cannabis on particular types of cancer.
"Legislation of cannabis use has been approved in many European and North American countries," noted the researchers. Despite this, the scientists declared that the impact of the herb on urological cancers "is unclear." This study was actually conducted "to explore the association between cannabis use and the risk of urological cancers."
Cannabis & Urological Cancers
The study's authors reported that they identified "151,945 individuals with information on cannabis use in the UK Biobank from 2006 to 2010," with a focus on different urological cancers.
The research reported that it found that "previous use of cannabis was a significant protective factor for renal cell carcinoma and prostate cancer."
The research reported that it found that "previous use of cannabis was a significant protective factor for renal cell carcinoma and prostate cancer." However, the investigation found "no significant association between cannabis use and testicular cancer incidence," meaning that, statistically, it was revealed that cannabis use neither caused or prevented the incidence of testicular cancer.
Copyright © Higher Learning LV™
The study's authors concluded that previous use of cannabis "was associated with a lower risk of bladder cancer, renal cell carcinoma, and prostate cancer."
The study also revealed "a potential causal effect of cannabis use on a lower incidence of renal cell carcinoma." The study's authors concluded that, from the data analyzed, previous use of cannabis "was associated with a lower risk of bladder cancer, renal cell carcinoma, and prostate cancer."
View the original study.